0000904454-24-000112.txt : 20240206 0000904454-24-000112.hdr.sgml : 20240206 20240206172839 ACCESSION NUMBER: 0000904454-24-000112 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240206 DATE AS OF CHANGE: 20240206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaye Jack CENTRAL INDEX KEY: 0001376099 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36294 FILM NUMBER: 24601348 MAIL ADDRESS: STREET 1: C/O KERYX BIOPHARMACEUTICALS STREET 2: 750 LEXINGTON AVENUE CITY: NEW YORK STATE: X1 ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: uniQure N.V. CENTRAL INDEX KEY: 0001590560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: PAASHEUVELWEG 25A CITY: AMSTERDAM STATE: P7 ZIP: 1105 BP BUSINESS PHONE: 1-339-970-7000 MAIL ADDRESS: STREET 1: PAASHEUVELWEG 25A CITY: AMSTERDAM STATE: P7 ZIP: 1105 BP FORMER COMPANY: FORMER CONFORMED NAME: uniQure B.V. DATE OF NAME CHANGE: 20131030 5 1 ownership.xml X0508 5 2023-12-31 0 0 1 0001590560 uniQure N.V. QURE 0001376099 Kaye Jack C/O UNIQURE N.V. PAASHEUVELWEG 25A AMSTERDAM P7 11058BP NETHERLANDS 1 0 0 0 0 Ordinary Shares 2023-06-23 4 G 0 L 12700 0 D 21419 D Ordinary Shares 2023-06-23 4 G 0 L 12700 0 D 8719 D On June 23, 2023, the Reporting Person, in connection with his estate plan, made a gift of 12,700 shares to each of his adult children. These were bona fide gifts for no consideration. Mr. Kaye has not retained any voting or dispositive power over such gifted shares. /s/ Christian Klemt, Attorney-in-Fact 2024-02-06